Ranbaxy Laboratories Ltd Merged Annually Results

Gross Sales

13,040.32

10,604.19

12,252.88

9,970

8,550.66

Excise Duty

0

0

0

0

15.22

Net Sales

13,040.32

10,604.19

12,252.88

9,970

8,535.45

Other Operating Income

228.16

197.47

206.83

259.51

425.32

Other Income

182.83

159.13

273.17

182.19

1,097.47

Total Income

13,451.32

10,960.79

12,732.9

10,411.71

10,058.25

Total Expenditure

13,635.8

10,907.65

10,864.16

12,397.75

7,525.02

PBIDT

-184.5

53.15

1,868.73

-1,986.03

2,533.22

Interest

557.26

443.69

303.6

306.42

61.38

PBDT

-741.76

-390.54

1,565.14

-2,292.45

2,471.84

Depreciation

0

380.85

320.25

394.01

371.73

Minority Interest Before NP

0

0

0

0

0

Tax

331.45

221.58

293.89

196.94

144.75

Deferred Tax

0

0

0

0

440.13

Reported Profit After Tax

-1,073.2

-992.98

950.98

-2,883.41

1,515.22

Minority Interest After NP

-2

3.66

9.64

9.72

12.56

Net Profit after Minority Interest

-1,085.25

-1,011.59

922.76

-2,899.72

1,496.75

Extra-ordinary Items

-478.1

-662.86

-173.52

-3,537.55

197.78

Adjusted Profit After Extra-ordinary item

-607.14

-348.72

1,096.29

637.82

1,298.96

EPS (Unit Curr.)

-25.65

-23.93

21.87

-68.8

35.56

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

40

Equity

211.66

211.55

211.46

211

210.52

Public Shareholding (Number)

14,87,73,664

14,80,01,952

14,52,39,376

14,58,27,552

14,59,97,152

Public Shareholding (%)

35.11

34.93

34.34

34.56

34.68

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

26,87,11,328

26,87,11,328

26,87,11,328

26,87,11,328

26,87,11,328

Non Encumbered - % in Total Promoters Holding

100

100

100

100

100

Non Encumbered - % in Total Equity

63.4

63.4

63.54

63.68

63.81

PBIDTM(%)

-1.41

0.5

15.25

-19.92

29.67

PBDTM(%)

-5.68

-3.68

12.77

-22.99

28.95

PATM(%)

-8.22

-9.36

7.76

-28.92

17.75